FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Jun 16, 2011
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on June 16, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- June 16, 2011
- Product Type
- Biologics
View Company Profile
ID · 57126e6e-71be-4bb7-8c42-9d6d151714d7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 732307
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 10, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 12, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 29, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 20, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1151483 - 2021-08-06
- FDA Inspection 1097088 - 2019-07-10
- FDA Inspection 988682 - 2016-10-12
- FDA Inspection 928408 - 2015-05-29
- FDA Inspection 849108 - 2013-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.